arrow
Y

Yinzhi Lai

Bristol Myers Squibb
H指数:17
被引数:1,164

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study

luspaterecpt 在非输血依赖性β-地中海贫血中的有效性和安全性:BEYOND研究的长期能力结果

2025-09-010
OAAI
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial

COMMANDS试验中,与促红细胞生成素α相比,鲁斯帕特塞普特在促红细胞生成素刺激剂初治、低危骨髓增生异常综合征患者中的长期输血独立性。

2025-05-160
OA
Luspatercept versus epoetin alfa in erythropoiesisstimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
2024-09-011
PRE
Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts
LEUKEMIA
IF13.4
2023-09-265
OAAI